Roland Veltkamp Selected Research

Pathologic Constriction (Stenosis)

5/2022	Recovery of intracranial stenoses in varicella zoster virus vasculitis after long-term treatment with valacyclovir and prednisolone.
6/2018	Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Roland Veltkamp Research Topics

Disease

79	Stroke (Strokes) 05/2024 - 01/2009
45	Ischemic Stroke 05/2024 - 03/2008
24	Atrial Fibrillation 05/2024 - 12/2011
22	Brain Ischemia (Cerebral Ischemia) 01/2017 - 11/2002
21	Cerebral Hemorrhage 05/2024 - 03/2010
19	Hemorrhage 01/2022 - 09/2010
15	Ischemia 08/2023 - 11/2002
14	Hematoma 05/2024 - 03/2010
9	Infarction (Infarctions) 03/2017 - 02/2009
8	Embolic Stroke 01/2021 - 09/2016
7	Embolism (Embolus) 12/2022 - 09/2016
7	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2019 - 03/2008
6	Intracranial Hemorrhages (Intracranial Hemorrhage) 04/2024 - 09/2014
6	Brain Injuries (Brain Injury) 07/2016 - 01/2009
6	Neuroinflammatory Diseases 04/2016 - 01/2011
5	Hyperoxia 08/2014 - 10/2007
4	Hypertension (High Blood Pressure) 04/2024 - 03/2009
4	Thrombosis (Thrombus) 01/2022 - 01/2011
4	Bacterial Infections (Bacterial Infection) 01/2017 - 03/2011
4	Infections 02/2013 - 10/2009
3	Transient Ischemic Attack 04/2024 - 08/2006
3	Pneumonia (Pneumonitis) 03/2017 - 03/2011
3	Hypoxia (Hypoxemia) 02/2015 - 03/2008
3	Edema (Dropsy) 02/2015 - 08/2005
3	Lymphopenia (Lymphocytopenia) 10/2014 - 01/2011
2	Vasculitis (Vasculitides) 05/2022 - 05/2019
2	Pathologic Constriction (Stenosis) 05/2022 - 06/2018
2	Hemorrhagic Stroke 01/2021 - 09/2015
2	Patent Foramen Ovale 01/2020 - 12/2018
2	Brain Infarction 09/2016 - 10/2014
2	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2013 - 01/2009
1	Neurologic Manifestations (Neurological Manifestations) 05/2024
1	Rare Diseases (Rare Disease) 05/2024
1	Wounds and Injuries (Trauma) 03/2024
1	Encephalitis (Encephalitis, Rasmussen) 05/2023
1	Primary angiitis of the central nervous system 02/2022
1	Central Nervous System Vasculitis 02/2022
1	Chronic Renal Insufficiency 01/2021
1	Neoplasms (Cancer) 01/2020

Drug/Important Bio-Agent (IBA)

43	AnticoagulantsIBA 04/2024 - 11/2009
21	Vitamin K FDA Link 01/2023 - 06/2010
12	Oxygen (Dioxygen)IBA 08/2023 - 03/2005
10	RivaroxabanIBA 01/2021 - 03/2013
10	N(4)-oleylcytosine arabinosideIBA 06/2019 - 03/2014
10	CytokinesIBA 01/2017 - 02/2009
7	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 09/2016
7	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2011
6	Hemostatics (Antihemorrhagics)IBA 05/2024 - 03/2010
6	Factor Xa (Coagulation Factor Xa)IBA 01/2021 - 07/2014
6	Warfarin (Coumadin)FDA LinkGeneric 03/2017 - 03/2010
5	Factor Xa InhibitorsIBA 05/2024 - 09/2016
5	salicylhydroxamic acid (SHAM)IBA 01/2019 - 03/2011
5	Prothrombin (Factor II)IBA 02/2016 - 12/2010
4	Factor VIIa (Activated Factor VII)IBA 09/2017 - 01/2011
4	Dabigatran FDA Link 01/2017 - 12/2011
4	Collagenases (Collagenase)FDA Link 02/2015 - 01/2011
3	Proteins (Proteins, Gene)FDA Link 05/2023 - 11/2002
3	AntigensIBA 12/2014 - 06/2012
3	Tissue Plasminogen Activator (Alteplase)FDA Link 03/2014 - 04/2009
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2013 - 06/2012
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 12/2023 - 11/2013
2	edoxabanIBA 12/2021 - 11/2018
2	Natalizumab (Tysabri)FDA Link 01/2020 - 03/2017
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 03/2008
2	Tranexamic Acid (AMCA)FDA Link 09/2017 - 01/2011
2	Ketamine FDA LinkGeneric 07/2016 - 08/2012
2	HMGB1 Protein (HMG1)IBA 04/2016 - 01/2015
2	Hemoglobins (Hemoglobin)IBA 07/2015 - 03/2014
2	Protein Isoforms (Isoforms)IBA 01/2015 - 10/2012
2	Monoclonal AntibodiesIBA 01/2015 - 03/2011
2	Hormones (Hormone)IBA 10/2014 - 01/2013
2	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2014 - 01/2013
2	Interleukin-10 (Interleukin 10)IBA 09/2014 - 02/2009
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2014 - 01/2014
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2013 - 11/2010
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2012 - 03/2008
2	Phenprocoumon (Liquamar)FDA Link 06/2010 - 01/2009
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2009 - 02/2009
1	eculizumab FDA Link 05/2024
1	PRT064445IBA 05/2024
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2024
1	Glucose (Dextrose)FDA LinkGeneric 03/2024
1	LigandsIBA 05/2023
1	APTIBA 12/2022
1	Valacyclovir (Valtrex)FDA LinkGeneric 05/2022
1	Prednisolone (Predate)FDA LinkGeneric 05/2022
1	Prednisone (Sone)FDA LinkGeneric 05/2022
1	Nimodipine (Modus)FDA LinkGeneric 02/2022
1	Factor XIa (Coagulation Factor XIa)IBA 01/2022

Therapy/Procedure

41	Therapeutics 05/2024 - 08/2005
6	Secondary Prevention 04/2024 - 01/2009
6	Thrombectomy 08/2023 - 04/2016
4	Length of Stay 01/2022 - 05/2011
3	Emergency Treatment 06/2019 - 06/2010
2	Transcatheter Aortic Valve Replacement 12/2021 - 11/2018
2	Thrombolytic Therapy 01/2017 - 12/2011
2	Immunomodulation 10/2016 - 08/2009
2	Anticoagulation Reversal 02/2016 - 12/2011
2	Treatment Delay 12/2012 - 10/2007
2	Lasers (Laser) 09/2011 - 04/2009